Ovarian Cycle Stages Modulate Alzheimer-Related Cognitive and Brain Network Alterations in Female Mice

Visual Abstract Alzheimer’s disease (AD) begins several decades before the onset of clinical symptoms, at a time when women may still undergo reproductive cycling. Whether ovarian functions alter substrates of AD pathogenesis is unknown. Here we show that ovarian cycle stages significantly modulate AD-related alterations in neural network patterns, cognitive impairments, and pathogenic protein production in the hAPP-J20 mouse model of AD. Female hAPP mice spent more time in estrogen-dominant cycle stages and these ovarian stages worsened AD-related network dysfunction and cognitive impairments. In contrast, progesterone-dominant stages and gonadectomy attenuated these AD-related deficits. Further studies revealed a direct role for estradiol in stimulating neural network excitability and susceptibility to seizures in hAPP mice and increasing amyloid beta levels. Understanding dynamic effects of the ovarian cycle on the female nervous system in disease, including AD, is of critical importance and may differ from effects on a healthy brain. The pattern of ovarian cycle effects on disease-related networks, cognition, and pathogenic protein expression may be relevant to young women at risk for AD.

[1]  M. Álvarez-Dolado,et al.  Nav1.1-Overexpressing Interneuron Transplants Restore Brain Rhythms and Cognition in a Mouse Model of Alzheimer’s Disease , 2018, Neuron.

[2]  Marc Edwards,et al.  Seizures in Alzheimer’s disease: is there more beneath the surface? , 2017, Journal of Neurology.

[3]  K. Vossel,et al.  Epileptic activity in Alzheimer's disease: causes and clinical relevance , 2017, The Lancet Neurology.

[4]  Alice D. Lam,et al.  Silent Hippocampal Seizures and Spikes Identified by Foramen Ovale Electrodes in Alzheimer’s Disease , 2017, Nature Medicine.

[5]  L. Mucke,et al.  Network abnormalities and interneuron dysfunction in Alzheimer disease , 2016, Nature Reviews Neuroscience.

[6]  L. Mucke,et al.  Life Extension Factor Klotho Prevents Mortality and Enhances Cognition in hAPP Transgenic Mice , 2015, The Journal of Neuroscience.

[7]  Francis S Collins,et al.  Policy: NIH to balance sex in cell and animal studies , 2014, Nature.

[8]  Jan Laczó,et al.  Behavioral Neuroscience Mini Review Article Neural Correlates of Spatial Navigation Changes in Mild Cognitive Impairment and Alzheimer's Disease , 2022 .

[9]  I. Ninan,et al.  Regulation of the Mouse Medial Prefrontal Cortical Synapses by Endogenous Estradiol , 2014, Neuropsychopharmacology.

[10]  T. Golde,et al.  Steroids as γ‐secretase modulators , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  Heidi E Kirsch,et al.  Seizures and epileptiform activity in the early stages of Alzheimer disease. , 2013, JAMA neurology.

[12]  O. Sporns Structure and function of complex brain networks , 2013, Dialogues in clinical neuroscience.

[13]  Chengjie Xiong,et al.  Impaired default network functional connectivity in autosomal dominant Alzheimer disease , 2013, Neurology.

[14]  O. Gangisetty,et al.  Estrous Cycle Regulation of Extrasynaptic δ-Containing GABAA Receptor-Mediated Tonic Inhibition and Limbic Epileptogenesis , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[15]  Kai-Florian Storch,et al.  Global but not gonadotrope-specific disruption of Bmal1 abolishes the luteinizing hormone surge without affecting ovulation. , 2013, Endocrinology.

[16]  A. Gogos,et al.  Natural and synthetic sex hormones: Effects on higher-order cognitive function and prepulse inhibition , 2013, Biological Psychology.

[17]  C. Rowe,et al.  Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study , 2013, The Lancet Neurology.

[18]  D. Reddy Neuroendocrine aspects of catamenial epilepsy , 2013, Hormones and Behavior.

[19]  A. Wimo,et al.  The global prevalence of dementia: A systematic review and metaanalysis , 2013, Alzheimer's & Dementia.

[20]  Kewei Chen,et al.  Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study , 2012, The Lancet Neurology.

[21]  L. Broestl,et al.  Sex and gonadal hormones in mouse models of Alzheimer’s disease: what is relevant to the human condition? , 2012, Biology of Sex Differences.

[22]  Adam W. Bero,et al.  Disruption of the Sleep-Wake Cycle and Diurnal Fluctuation of β-Amyloid in Mice with Alzheimer’s Disease Pathology , 2012, Science Translational Medicine.

[23]  Nick C Fox,et al.  Clinical and biomarker changes in dominantly inherited Alzheimer's disease. , 2012, The New England journal of medicine.

[24]  J. T. Smith,et al.  Effects of aging and genotype on circadian rhythms, sleep, and clock gene expression in APPxPS1 knock-in mice, a model for Alzheimer's disease , 2012, Experimental Neurology.

[25]  Amy L. Shelton,et al.  Reduction of Hippocampal Hyperactivity Improves Cognition in Amnestic Mild Cognitive Impairment , 2012, Neuron.

[26]  Edward O. Mann,et al.  Inhibitory Interneuron Deficit Links Altered Network Activity and Cognitive Dysfunction in Alzheimer Model , 2012, Cell.

[27]  Gregory F Ball,et al.  Sex Differences in the Brain: The Not So Inconvenient Truth , 2012, The Journal of Neuroscience.

[28]  J. Balthazart,et al.  Milestones on Steroids and the Nervous System: 10 Years of Basic and Translational Research , 2012, Journal of neuroendocrinology.

[29]  D. Egli,et al.  Aging of the Female Reproductive System , 2011 .

[30]  G. Frisoni,et al.  Functional network disruption in the degenerative dementias , 2011, The Lancet Neurology.

[31]  C. Woolley,et al.  Estradiol potentiation of NR2B‐dependent EPSCs is not due to changes in NR2B protein expression or phosphorylation , 2011, Hippocampus.

[32]  L. Mucke,et al.  Amyloid-β/Fyn–Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease , 2011, The Journal of Neuroscience.

[33]  Julie Harris,et al.  Reversing EphB2 depletion rescues cognitive functions in Alzheimer model , 2011, Nature.

[34]  R. Dyck,et al.  Characterization of the 3xTg-AD mouse model of Alzheimer's disease: Part 1. Circadian changes , 2010, Brain Research.

[35]  Jürgen Götz,et al.  Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models , 2010, Cell.

[36]  L. Mucke,et al.  Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks , 2010, Nature Neuroscience.

[37]  R. Sperling,et al.  Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline , 2010, Neurology.

[38]  I. Zucker,et al.  Males still dominate animal studies , 2010, Nature.

[39]  C. Pike,et al.  Continuous and cyclic progesterone differentially interact with estradiol in the regulation of Alzheimer-like pathology in female 3xTransgenic-Alzheimer's disease mice. , 2010, Endocrinology.

[40]  C. Frye Neurosteroids’ effects and mechanisms for social, cognitive, emotional, and physical functions , 2009, Psychoneuroendocrinology.

[41]  L. Mucke,et al.  Epilepsy and cognitive impairments in Alzheimer disease. , 2009, Archives of neurology.

[42]  Sylvain Rheims,et al.  Amyloid β-Induced Neuronal Hyperexcitability Triggers Progressive Epilepsy , 2009, The Journal of Neuroscience.

[43]  C. Woolley,et al.  Estradiol Facilitates the Release of Neuropeptide Y to Suppress Hippocampus-Dependent Seizures , 2009, The Journal of Neuroscience.

[44]  A. Walf,et al.  Proestrous compared to diestrous wildtype, but not estrogen receptor beta knockout, mice have better performance in the spontaneous alternation and object recognition tasks and reduced anxiety-like behavior in the elevated plus and mirror maze , 2009, Behavioural Brain Research.

[45]  B. McEwen,et al.  Uncovering the mechanisms of estrogen effects on hippocampal function , 2008, Frontiers in Neuroendocrinology.

[46]  Richard F. Thompson,et al.  Progesterone receptors: Form and function in brain , 2008, Frontiers in Neuroendocrinology.

[47]  Frank Z. Stanczyk,et al.  Progesterone and Estrogen Regulate Alzheimer-Like Neuropathology in Female 3xTg-AD Mice , 2007, The Journal of Neuroscience.

[48]  Anatol C. Kreitzer,et al.  Aberrant Excitatory Neuronal Activity and Compensatory Remodeling of Inhibitory Hippocampal Circuits in Mouse Models of Alzheimer's Disease , 2007, Neuron.

[49]  P. Timiras,et al.  Physiological Basis of Aging and Geriatrics , 2007 .

[50]  L. Mucke,et al.  Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.

[51]  J. Morris,et al.  Fluctuations of CSF amyloid-β levels , 2007, Neurology.

[52]  H. Scharfman,et al.  The Influence of Gonadal Hormones on Neuronal Excitability, Seizures, and Epilepsy in the Female , 2006, Epilepsia.

[53]  L. McMahon,et al.  Estradiol-Induced Increase in the Magnitude of Long-Term Potentiation Is Prevented by Blocking NR2B-Containing Receptors , 2006, The Journal of Neuroscience.

[54]  Yaakov Stern,et al.  Incidence and Predictors of Seizures in Patients with Alzheimer's Disease , 2006, Epilepsia.

[55]  Steven Mennerick,et al.  Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo , 2005, Neuron.

[56]  E. Mackenzie,et al.  NMDA Receptor Activation Inhibits α-Secretase and Promotes Neuronal Amyloid-β Production , 2005, The Journal of Neuroscience.

[57]  I. Módy,et al.  Ovarian cycle–linked changes in GABAA receptors mediating tonic inhibition alter seizure susceptibility and anxiety , 2005, Nature Neuroscience.

[58]  E. Mackenzie,et al.  NMDA receptor activation inhibits alpha-secretase and promotes neuronal amyloid-beta production. , 2005, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[59]  David M Holtzman,et al.  Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. , 2005, Neuron.

[60]  JoAnn E Manson,et al.  Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. , 2004, JAMA.

[61]  B. H. Miller,et al.  Circadian Clock Mutation Disrupts Estrous Cyclicity and Maintenance of Pregnancy , 2004, Current Biology.

[62]  C. Frye,et al.  Estrogen has mnemonic-enhancing effects in the inhibitory avoidance task , 2004, Pharmacology Biochemistry and Behavior.

[63]  J. Morrison,et al.  Estrogen modulates synaptic N‐methyl‐D‐aspartate receptor subunit distribution in the aged hippocampus , 2004, The Journal of comparative neurology.

[64]  L. Thal,et al.  Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study , 2004, JAMA.

[65]  C. Woolley,et al.  Cellular and molecular effects of steroid hormones on CNS excitability. , 2004, Cleveland Clinic journal of medicine.

[66]  H. Scharfman,et al.  Hippocampal Excitability Increases during the Estrous Cycle in the Rat: A Potential Role for Brain-Derived Neurotrophic Factor , 2003, The Journal of Neuroscience.

[67]  Robert B Wallace,et al.  Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. , 2003, JAMA.

[68]  Guillén Fernández,et al.  Menstrual Cycle-Dependent Neural Plasticity in the Adult Human Brain Is Hormone, Task, and Region Specific , 2003, The Journal of Neuroscience.

[69]  R. Malinow,et al.  APP Processing and Synaptic Function , 2003, Neuron.

[70]  R Shayna Rosenbaum,et al.  Implicit memory varies across the menstrual cycle: estrogen effects in young women , 2002, Neuropsychologia.

[71]  J. Lafrancois,et al.  Modulation of Aβ peptides by estrogen in mouse models , 2002, Journal of neurochemistry.

[72]  Jonathan D. Smith,et al.  17α-estradiol and 17β-estradiol treatments are effective in lowering cerebral amyloid-β levels in AβPPSWE transgenic mice , 2002 .

[73]  J. Simpkins,et al.  Modulation of A(beta) peptides by estrogen in mouse models. , 2002, Journal of neurochemistry.

[74]  Jonathan D. Smith,et al.  17Alpha-estradiol and 17beta-estradiol treatments are effective in lowering cerebral amyloid-beta levels in AbetaPPSWE transgenic mice. , 2002, Journal of Alzheimer's disease : JAD.

[75]  C. Woolley,et al.  Estrogen Regulates Functional Inhibition of Hippocampal CA1 Pyramidal Cells in the Adult Female Rat , 2001, The Journal of Neuroscience.

[76]  C. Woolley,et al.  Estrogen increases synaptic connectivity between single presynaptic inputs and multiple postsynaptic CA1 pyramidal cells: A serial electron-microscopic study , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[77]  Kang Hu,et al.  High-Level Neuronal Expression of Aβ1–42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation , 2000, The Journal of Neuroscience.

[78]  C. Woolley Estradiol Facilitates Kainic Acid—Induced, but not Flurothyl‐Induced, Behavioral Seizure Activity in Adult Female Rats , 2000, Epilepsia.

[79]  G. Tassoni,et al.  Neural Topography and Chronology of Memory Consolidation: A Review of Functional Inactivation Findings , 1999, Neurobiology of Learning and Memory.

[80]  M. Segal,et al.  Estradiol Increases Dendritic Spine Density by Reducing GABA Neurotransmission in Hippocampal Neurons , 1998, The Journal of Neuroscience.

[81]  P. Greengard,et al.  Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. , 1998, Nature medicine.

[82]  P. Klein,et al.  Three Patterns of Catamenial Epilepsy , 1997, Epilepsia.

[83]  G. Johnston,et al.  SEX DIFFERENCES IN THE EFFECTS OF GONADECTOMY AND ACUTE SWIM STRESS ON GABAA RECEPTOR BINDING IN MOUSE FOREBRAIN MEMBRANES , 1997, Neurochemistry International.

[84]  C. Woolley,et al.  Estradiol Increases the Sensitivity of Hippocampal CA1 Pyramidal Cells to NMDA Receptor-Mediated Synaptic Input: Correlation with Dendritic Spine Density , 1997, The Journal of Neuroscience.

[85]  L. Mucke,et al.  Levels and Alternative Splicing of Amyloid β Protein Precursor (APP) Transcripts in Brains of APP Transgenic Mice and Humans with Alzheimer's Disease (*) , 1995, The Journal of Biological Chemistry.

[86]  P. Greengard,et al.  Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein. , 1994, The Journal of biological chemistry.

[87]  C. Woolley,et al.  Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat , 1993, The Journal of comparative neurology.

[88]  K. Nelson,et al.  Lactoferrin expression in the mouse reproductive tract during the natural estrous cycle: correlation with circulating estradiol and progesterone. , 1992, Endocrinology.

[89]  M. Le Moal,et al.  A two-trial memory task with automated recording: study in young and aged rats , 1992, Brain Research.

[90]  B. Mcewen,et al.  Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat [published erratum appears in J Neurosci 1992 Oct;12(10):following table of contents] , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[91]  E Gould,et al.  Naturally occurring fluctuation in dendritic spine density on adult hippocampal pyramidal neurons , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[92]  M M Mesulam,et al.  Large‐scale neurocognitive networks and distributed processing for attention, language, and memory , 1990, Annals of neurology.

[93]  S. Wiegand,et al.  Discrete lesions reveal functional heterogeneity of suprachiasmatic structures in regulation of gonadotropin secretion in the female rat. , 1982, Neuroendocrinology.

[94]  A. Parlow,et al.  Alterations in serum FSH-LH ratios in relation to the estrous cycle, pseudopregnancy, and gonadectomy in the mouse. , 1972, Endocrinology.

[95]  E. Terasawa,et al.  Electrical activity during the estrous cycle of the rat: cyclic changes in limbic structures. , 1968, Endocrinology.

[96]  E. Allen The oestrous cycle in the mouse , 1922 .